Literature DB >> 16420162

The effects of D1 or D2 dopamine receptor antagonism in the medial preoptic area, ventral pallidum, or nucleus accumbens on the maternal retrieval response and other aspects of maternal behavior in rats.

Michael Numan1, Marilyn J Numan, Natalia Pliakou, Danielle S Stolzenberg, Olivia J Mullins, Jennifer M Murphy, Carl D Smith.   

Abstract

The medial preoptic area (MPOA), ventral pallidum (VP), and nucleus accumbens (NA) receive dopaminergic afferents and are involved in maternal behavior. Experiments investigated whether dopamine (DA) receptor antagonism in NA disrupts maternal behavior, determined the type of DA receptor involved, and investigated the involvement of drug spread to VP or MPOA. Injection of SCH 23390 (D1 DA receptor antagonist) into NA of postpartum rats disrupted retrieving at dosage levels that were ineffective when injected into MPOA or VP. Motor impairment was not the cause of the deficit. Injection of eticlopride (D2 DA receptor antagonist) into NA or VP was without effect. Results emphasize the importance of DA action on D1 receptors in NA for retrieval behavior. Copyright (c) 2006 APA, all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16420162     DOI: 10.1037/0735-7044.119.6.1588

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  61 in total

Review 1.  Maternal neglect: oxytocin, dopamine and the neurobiology of attachment.

Authors:  L Strathearn
Journal:  J Neuroendocrinol       Date:  2011-11       Impact factor: 3.627

2.  Effects of noradrenergic alpha-2 receptor antagonism or noradrenergic lesions in the ventral bed nucleus of the stria terminalis and medial preoptic area on maternal care in female rats.

Authors:  Carl D Smith; M Allie Holschbach; Joshua Olsewicz; Joseph S Lonstein
Journal:  Psychopharmacology (Berl)       Date:  2012-05-29       Impact factor: 4.530

Review 3.  The ventral pallidum: Subregion-specific functional anatomy and roles in motivated behaviors.

Authors:  David H Root; Roberto I Melendez; Laszlo Zaborszky; T Celeste Napier
Journal:  Prog Neurobiol       Date:  2015-04-06       Impact factor: 11.685

Review 4.  Neural mechanisms of reproduction in females as a predisposing factor for drug addiction.

Authors:  Valerie L Hedges; Nancy A Staffend; Robert L Meisel
Journal:  Front Neuroendocrinol       Date:  2010-02-19       Impact factor: 8.606

Review 5.  Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits.

Authors:  J D Salamone; M Correa; A Farrar; S M Mingote
Journal:  Psychopharmacology (Berl)       Date:  2007-01-16       Impact factor: 4.530

6.  Effects of 5-hydroxytryptamine 2C receptor agonist MK212 and 2A receptor antagonist MDL100907 on maternal behavior in postpartum female rats.

Authors:  Weihai Chen; Qi Zhang; Wenxin Su; Haorong Zhang; Yu Yang; Jing Qiao; Nan Sui; Ming Li
Journal:  Pharmacol Biochem Behav       Date:  2013-12-07       Impact factor: 3.533

7.  Oxytocin and HPA stress axis reactivity in postpartum women.

Authors:  E Q Cox; A Stuebe; B Pearson; K Grewen; D Rubinow; S Meltzer-Brody
Journal:  Psychoneuroendocrinology       Date:  2015-02-25       Impact factor: 4.905

8.  Down-regulation of fatty acid binding protein 7 (Fabp7) is a hallmark of the postpartum brain.

Authors:  Terri M Driessen; Changjiu Zhao; Marissa Saenz; Sharon A Stevenson; Yuji Owada; Stephen C Gammie
Journal:  J Chem Neuroanat       Date:  2018-08-01       Impact factor: 3.052

9.  Exposure to pups influences the strength of maternal motivation in virgin female rats.

Authors:  Katharine M Seip; Joan I Morrell
Journal:  Physiol Behav       Date:  2008-09-09

10.  Nucleus accumbens dopamine mediates amphetamine-induced impairment of social bonding in a monogamous rodent species.

Authors:  Yan Liu; Brandon J Aragona; Kimberly A Young; David M Dietz; Mohamed Kabbaj; Michelle Mazei-Robison; Eric J Nestler; Zuoxin Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-29       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.